C-Bridge Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$86M
Portfolio companies 10
Rounds per year 1.50
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical
  • Biopharma
  • Pharmaceutical
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of C-Bridge Capital:
Typical Co-investors
C-Bridge Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after C-Bridge Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atlantica Ventures Lagos, Lagos, Nigeria
Beijing Xingchen Wenhua Chuanmei Beijing, China, Pinggu
Beta Bridge Capital New Jersey, Princeton, United States
CCFO Investments Afghanistan, Kabul, Kabul Province
Crossroads Capital Colorado, Greenwood Village, United States
DCapital -
Huaou Equity Investment China, Hangzhou, Zhejiang
Kunming Venture Capital China, Kunming, Yunnan
New York Presbyterian Ventures New York, New York, United States
Omron Ventures Chiba, Japan, Minato
ProVen VCT England, London, United Kingdom
Samsung Electronics Seoul, Seoul-t'ukpyolsi, South Korea
Sintokogio Aichi Prefecture, Japan, Nagoya
State Farm Ventures Bloomington, Illinois, United States
Stonehenge Partners Inc. Columbus, Ohio, United States
SuRo Capital California, San Francisco, United States
Sustainable Performance Group Mclean, United States, Virginia
TOM Capital Associates Alberta, Calgary, Canada
TPG Biotech California, San Francisco, United States
Yajie Shanghui Beijing, China, Haidian

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

RVAC Medicines

Biotechnology
Medical
Product Research
$140M26 Apr 2022 Singapore, Central Region, Singapore

NiKang Therapeutics

Biotechnology
Health Care
Medical
$200M26 May 2021 Wilmington, Delaware, United States

Adcentrx Therapeutics

Biotechnology
Pharmaceutical
$50M28 Apr 2021 San Diego, California, United States

Biopharma
Biotechnology
Pharmaceutical
$181M07 Dec 2020 Shanghai

GrayBug

Biotechnology
Health Care
Medical
$80M20 Aug 2019 Baltimore, Maryland, United States

I-Mab Biopharma

Biotechnology
Pharmaceutical
Product Research
$220M29 Jun 2018 Shanghai

Biopharma
Biotechnology
Pharmaceutical
$20M28 Jun 2018 Shanghai

Health Care
Health Diagnostics
Medical
$15M23 Apr 2018 Jiang'an District, Hubei, China

CMAB BioPharm

Biopharma
Biotechnology
Manufacturing
$34M02 Apr 2018 Gusu District, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent C-Bridge Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: